Spectrolyse Antithrombin III (Anti-Xa)
FDA 510(k) K960871 · Medical Diagnostic Technologies, Inc.
510(k) numberK960871
Submission
- Device name
- Spectrolyse Antithrombin III (Anti-Xa)
- Applicant
- Medical Diagnostic Technologies, Inc.
Ventura, CA, US - Received
- March 4, 1996
- Decision date
- August 14, 1996
- Decision
- Substantially Equivalent (SESE)
- Type
- Traditional 510(k)
- Summary
- 510(k) statement available from FDA
Device classification
- Product code
- JBQ – Antithrombin Iii Quantitation
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 864.7060
- Specialty
- Hematology
Other 510(k)s with product code JBQ
| 510(k) | Device | Applicant | Decision |
|---|---|---|---|
| K242952 | INNOVANCE AntithrombinJBQ · Traditional | Siemens Healthcare Diagnostic Products GmbH | 03/28/2025SE |
| K081769 | Innovance Antithrombin with Models OPFH03, OPFHO5JBQ · Traditional | Siemens Healthcare Diagnostics | 05/28/2009SE |
| K070301 | Hemosil AntithrombinJBQ · Special | Instrumentation Laboratory CO | 02/23/2007SE |
| K062431 | Hemosil Liquid AntithrombinJBQ · Special | Instrumentation Laboratory CO | 09/01/2006SE |
| K043007 | Biophen Antithrombin 2.5, Reference # 221102; Biophen Antithrombin 5, Reference # 221105JBQ · Traditional | Hyphen Biomed | 11/07/2005SE |
| K033775 | Hemosil Liquid Antithrombin XLJBQ · Special | Instrumentation Laboratory CO | 01/02/2004SE |
| K023991 | Chromocheck Antithrombin 25; Chromocheck Antithrombin 50JBQ · Traditional | Precision Biologic | 04/28/2003SE |
| K022550 | Coamatic LR Antithrombin, Note: Lr=Liquid ReagentsJBQ · Traditional | Instrumentation Laboratory CO | 08/27/2002SE |
| K022195 | Coamatic AT-400JBQ · Traditional | Instrumentation Laboratory CO | 08/07/2002SE |
| K994238 | Il Test Liquid AntithrombinJBQ · Traditional | Instrumentation Laboratory CO | 06/23/2000SE |
More from Instrumentation Laboratory CO
| 510(k) | Device | Decision |
|---|---|---|
| K062229 | CTC Workstation, Model 2200LLZ · Traditional | 09/11/2006SE |
| K972209 | Spectrolyse Heparin (Anti-Iia)KFF · Traditional | 08/12/1997SE |
| K963106 | Chromolize PAI-1 KitGGP · Traditional | 11/18/1996SE |
| K962489 | Chromolize Tpa Assay KitGGP · Traditional | 07/31/1996SE |
| K960438 | Tintelize PAI-1 KitGGP · Traditional | 06/05/1996SE |
| K961724 | U-Doa ControlsDIF · Traditional | 06/03/1996SE |
| K961370 | La Positive Control PlasmaGGC · Traditional | 05/24/1996SE |
| K955115 | Venom Tiem ReagentJCO · Traditional | 04/03/1996SE |
| K955738 | Bioclot Protein SGGP · Traditional | 02/29/1996SE |
| K952746 | Alkaline Phosphatase Reagent SystemCJE · Traditional | 11/27/1995SE |
Questions and answers
When was Spectrolyse Antithrombin III (Anti-Xa) cleared by the FDA?
Spectrolyse Antithrombin III (Anti-Xa) (K960871) received a 510(k) decision of Substantially Equivalent on August 14, 1996, 163 days after the submission was received.
What is the product code of K960871?
The FDA product code is JBQ – Antithrombin Iii Quantitation, a Class II (moderate risk) device regulated under 21 CFR 864.7060.